Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.

Abstract: Disclosed are microcapsules with shells that are not animal by-products and methods for preparing and using such microcapsules.

Abstract: The present invention relates in general to a shelf-stable liquid enteral composition for providing nutrition, either as a supplement, or as a complete nutrition, with a high protein content of a non-hydrolysed globular protein, in particular a whey protein.

Abstract: The present invention concerns liquid enteral nutritional compositions that comprise intact protein with a low specific volume allowing the preparation of nutrition with high protein and energy contents which are particularly advantageous for persons that are in, or recovering from, a disease state, persons that are malnourished or sportsmen and women and active elderly.

Abstract: Preferred embodiments of the present invention relate to exercise performance and recovery formulations. The exercise performance formulation, according to some embodiments, can be used in sports drinks to enhance endurance and decrease muscle recovery time, thereby improving performance. In other embodiments, the exercise recovery formulation, which can also be used in sports drinks, optimizes recovery from exercise, stimulates muscle glycogen repletion, tissue repair and protein synthesis, and enhances the rate of training adaptation. A dual formulation system comprising both the performance and recovery formulations is also provided.